{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:47:14Z","timestamp":1773082034386,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00213-009-1515-6","type":"journal-article","created":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T11:51:40Z","timestamp":1237895500000},"page":"53-62","source":"Crossref","is-referenced-by-count":57,"title":["The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial"],"prefix":"10.1007","volume":"205","author":[{"given":"Anders","family":"Hammarberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitya","family":"Jayaram-Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Franck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm S.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"1515_CR1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1530-0277.1995.tb01475.x","volume":"19","author":"RF Anton","year":"1995","unstructured":"Anton RF, Moak DH, Latham P (1995) The Obsessive-Compulsive Drinking Scale; a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alc Clin Exp Res 19:92\u201399","journal-title":"Alc Clin Exp Res"},{"issue":"6","key":"1515_CR2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.npp.1300657","volume":"30","author":"D Bachteler","year":"2005","unstructured":"Bachteler D, Economidou D, Danysz W, Ciccocioppo R, Spanagel R (2005) The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. Neuropsychopharmacology 30(6):1104\u20131110","journal-title":"Neuropsychopharmacology"},{"key":"1515_CR3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1530-0277.1998.tb04295.x","volume":"22","author":"J Besson","year":"1998","unstructured":"Besson J, Aeby F, Kasas A, Lehert P, Potgieter A (1998) Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alc Clin and Exp Res 22:573\u2013579","journal-title":"Alc Clin and Exp Res"},{"issue":"1","key":"1515_CR4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1369-1600.2008.00097.x","volume":"13","author":"C Burattini","year":"2008","unstructured":"Burattini C, McGeehan AJ, Griffin WC 3rd, Gass JT, Kinder JR, Janak PH, Olive MF (2008) A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration. Addict Biol 13(1):70\u201379","journal-title":"Addict Biol"},{"issue":"2","key":"1515_CR5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/alcalc\/35.2.176","volume":"35","author":"J Chick","year":"2000","unstructured":"Chick J, Howlett H, Morgan MY, Ritson B (2000) United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alc & Alc 35(2):176\u2013187","journal-title":"Alc & Alc"},{"issue":"4","key":"1515_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s002130050009","volume":"147","author":"JC Cole","year":"2000","unstructured":"Cole JC, Littleton JM, Little HJ (2000) Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze. Psychopharmacology (Berl) 147(4):403\u2013411","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"1515_CR7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/13556210500223132","volume":"10","author":"MS Cowen","year":"2005","unstructured":"Cowen MS, Adams C, Kraehenbuehl T, Vengeliene V, Lawrence AJ (2005) The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. Addict Biol 10(3):233\u2013242","journal-title":"Addict Biol"},{"issue":"2","key":"1515_CR8","first-page":"107","volume":"82","author":"A Dahchour","year":"1998","unstructured":"Dahchour A, De Witte P, Bolo N, N\u00e9d\u00e9lec JF, Muzet M, Durbin P, Macher JP (1998) Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 82(2):107\u201314","journal-title":"Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res"},{"issue":"2","key":"1515_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1530-0277.1999.tb04099.x","volume":"23","author":"D Davidson","year":"1999","unstructured":"Davidson D, Palfai T, Bird C, Swift R (1999) Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcohol Clin Exp Res 23(2):195\u2013203","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"1515_CR10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00023210-200519060-00004","volume":"19","author":"P Witte De","year":"2005","unstructured":"De Witte P, Littleton J, Parot P, Koob G (2005) Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs 19(6):517\u2013537 Review","journal-title":"CNS Drugs"},{"issue":"2","key":"1515_CR11","first-page":"86","volume":"23","author":"CC DiClemente","year":"1999","unstructured":"DiClemente CC, Bellino LE, Neavins TM (1999) Motivation for change and alcoholism treatment. Alcohol Res Health 23(2):86\u201392","journal-title":"Alcohol Res Health"},{"issue":"1","key":"1515_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1360-0443.2001.961333.x","volume":"96","author":"DC Drummond","year":"2001","unstructured":"Drummond DC (2001) Theories of drug craving, ancient and modern. Addiction 96(1):33\u201346","journal-title":"Addiction"},{"issue":"8","key":"1515_CR13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","volume":"23","author":"BA Flannery","year":"1999","unstructured":"Flannery BA, Volpicelli JR, Pettinati HM (1999) Psychometric properties of the penn alcohol craving scale. Alcohol Clin Exp Res 23(8):1289\u20131295","journal-title":"Clin Exp Res"},{"issue":"1","key":"1515_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199302000-00001","volume":"4","author":"RR Griffiths","year":"1993","unstructured":"Griffiths RR, Troisi JR, Silverman K, Mumford GK (1993) Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 4(1):3\u201313","journal-title":"Behav Pharmacol"},{"issue":"5","key":"1515_CR15","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1530-0277.1997.tb03850.x","volume":"21","author":"SM H\u00f6lter","year":"1997","unstructured":"H\u00f6lter SM, Landgraf R, Zieglg\u00e4nsberger W, Spanagel R (1997) Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res 21(5):862\u2013868","journal-title":"Alcohol Clin Exp Res"},{"key":"1515_CR16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","volume":"298","author":"BA Johnson","year":"2007","unstructured":"Johnson BA, Rosenthal MD, Capece JA, Wiegand F, Mao L, Beyers K, McKay A et al (2007) Topiramate for treating alcohol dependence. JAMA 298:1641\u20131651","journal-title":"JAMA"},{"issue":"4","key":"1515_CR17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.31887\/DCNS.2007.9.4\/pkalivas","volume":"9","author":"PW Kalivas","year":"2007","unstructured":"Kalivas PW (2007) Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci 9(4):389\u2013397","journal-title":"Dialogues Clin Neurosci"},{"key":"1515_CR18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","volume":"60","author":"F Kiefer","year":"2003","unstructured":"Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach P, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann W (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psych 60:92\u201399","journal-title":"Arch Gen Psych"},{"issue":"1","key":"1515_CR19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biopsych.2005.11.023","volume":"60","author":"F Kiefer","year":"2006","unstructured":"Kiefer F, Jahn H, Otte C, Naber D, Wiedemann K (2006) Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment? Biol Psych 60(1):74\u20136","journal-title":"Biol Psych"},{"issue":"7","key":"1515_CR20","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1360-0443.1998.937109113.x","volume":"93","author":"A Love","year":"1998","unstructured":"Love A, James D, Willner P (1998) A comparison of two alcohol craving questionnaires. Addiction 93(7):1091\u20131102","journal-title":"Addiction"},{"issue":"1","key":"1515_CR21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1530-0277.1993.tb00739.x","volume":"17","author":"CS Martin","year":"1993","unstructured":"Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM (1993) Development and validation of the Biphasic Alcohol Effects Scale. Alc Clin Exp Res 17(1):140\u2013146","journal-title":"Alc Clin Exp Res"},{"issue":"11","key":"1515_CR22","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1586\/14737175.7.11.1465","volume":"7","author":"BJ Mason","year":"2007","unstructured":"Mason BJ, Crean R (2007) Acamprosate in the treatment of alcohol dependence: clinical and economic considerations. Expert Rev Neurother 7(11):1465\u20131477","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"1515_CR23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpsychires.2006.02.002","volume":"40","author":"BJ Mason","year":"2006","unstructured":"Mason BJ, Goodman AM, Chabac S, Lehert P (2006) Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res 40(5):383\u2013393 Epub 2006 Mar 20","journal-title":"J Psychiatr Res"},{"key":"1515_CR24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1530-0277.1989.tb00340.x","volume":"13","author":"ME McCaul","year":"1989","unstructured":"McCaul ME, Turkkan JS, Stitzer ML (1989) Psychophysiological effects of alcohol-related stimuli. I. The role of stimulus intensity. Alcoholism: Clin. Exp. Res. 13:386\u2013398","journal-title":"Alcoholism: Clin. Exp. Res."},{"issue":"10","key":"1515_CR25","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1360-0443.2006.01555.x","volume":"101","author":"KC Morley","year":"2006","unstructured":"Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N et al (2006) Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 101(10):1451\u20131462","journal-title":"Addiction"},{"issue":"1\u20132","key":"1515_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(02)01272-4","volume":"437","author":"MF Olive","year":"2002","unstructured":"Olive MF, Nannini MA, Ou CJ, Koenig HN, Hodge CW (2002) Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. Eur J Pharmacol 437(1\u20132):55\u201361","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1515_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130100919","volume":"160","author":"SS O'Malley","year":"2002","unstructured":"O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) 160(1):19\u201329","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"1515_CR28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.euroneuro.2007.02.012","volume":"17","author":"W Ooteman","year":"2007","unstructured":"Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W (2007) The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. Eur Neuropsychopharmacol 17(8):558\u2013566","journal-title":"Eur Neuropsychopharmacol"},{"key":"1515_CR29","first-page":"239","volume":"30","author":"FM Paille","year":"1995","unstructured":"Paille FM, Guelfi JD, Perkins AC, Royer RJ, Stern L, Parot P (1995) Double-blind randomised multicentre trial of acamprosate in maintaining abstinence from alcohol. Alc & Alc 30:239\u2013247","journal-title":"Alc & Alc"},{"key":"1515_CR30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1192\/bjp.171.1.73","volume":"171","author":"I Pelc","year":"1997","unstructured":"Pelc I, Verbanck P, Le Bon O, Gavrilovic M, Lion K, Lehert P (1997) Efficacy and safety of acamprosate in the treatment of detoxified alcohol dependent patients: a 90\u00a0days placebo- controlled dose finding study. Brit J of Psych 171:73\u201377","journal-title":"Brit J of Psych"},{"issue":"6","key":"1515_CR31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0028-3908(01)00008-9","volume":"40","author":"G Rammes","year":"2001","unstructured":"Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, Spanagel R, Zieglg\u00e4nsberger W, Schadrack J (2001) The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology 40(6):749\u2013746","journal-title":"Neuropharmacology"},{"key":"1515_CR32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00702-005-0439-5","volume":"113","author":"MS Reid","year":"2006","unstructured":"Reid MS, Flammino F, Starosta F, Palamar FJ (2006) Physiological and subjective responding to alcohol cue exposure in alcoholics and control subjects: evidence for appetitive responding. J Neural Transm 113:1519\u20131535","journal-title":"J Neural Transm"},{"issue":"1","key":"1515_CR33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3565(25)21776-1","volume":"229","author":"C Rivier","year":"1984","unstructured":"Rivier C, Bruhn T, Vale W (1984) Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther 229(1):127\u2013131","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"1515_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(96)00301-0","volume":"726","author":"C Rivier","year":"1996","unstructured":"Rivier C, Lee S (1996) Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin. Brain Res 726(1\u20132):1\u201310","journal-title":"Brain Res"},{"issue":"3","key":"1515_CR35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1037\/0893-164X.19.3.263","volume":"19","author":"MA Sayette","year":"2005","unstructured":"Sayette MA, Martin CS, Wertz JM, Perrott MA, Peters AR (2005) The effects of alcohol on cigarette craving in heavy smokers and tobacco chippers. Psychol Addict Behav 19(3):263\u2013270","journal-title":"Psychol Addict Behav"},{"key":"1515_CR36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archpsyc.1996.01830080023006","volume":"53","author":"H Sass","year":"1996","unstructured":"Sass H, Soyka M, Mann K, Zieglegansberger W (1996) Relapse prevention by acamprosate: Results from a placebo-controlled study on alcohol dependence. Arch Gen Psych 53:673\u2013680","journal-title":"Arch Gen Psych"},{"key":"1515_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption","author":"LC Sobell","year":"1992","unstructured":"Sobell LC, Sobell MB (1992) Timeline Follow Back. A technique for assessing self-reported alcohol consumption. In: Litten R, Allen J (eds) Measuring Alcohol Consumption. Humana Press, Totowa, pp 41\u201372"},{"issue":"1\u20133","key":"1515_CR38","first-page":"39","volume":"305","author":"R Spanagel","year":"1996","unstructured":"Spanagel R, H\u00f6lter SM, Allingham K, Landgraf R, Zieglg\u00e4nsberger W (1996) Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305(1\u20133):39\u201344","journal-title":"Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol"},{"issue":"11","key":"1515_CR39","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","volume":"84","author":"JT Sullivan","year":"1989","unstructured":"Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84(11):1353\u20131357","journal-title":"Br J Addict"},{"key":"1515_CR40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/alcalc\/35.2.202","volume":"35","author":"E Tempesta","year":"2000","unstructured":"Tempesta E, Janiri L, Bignamini A, Chabac S, Potgieter A (2000) Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo controlled study. Alc & Alc 35:202\u2013209","journal-title":"Alc & Alc"},{"issue":"11","key":"1515_CR41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman Al, Hayashida M, O\u2019Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49(11):876\u2013880","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"1515_CR42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","volume":"54","author":"D Watson","year":"1998","unstructured":"Watson D, Clark LA, Tellegren A (1998) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54(6):1063\u20131070","journal-title":"J Pers Soc Psychol"},{"key":"1515_CR43","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(96)91682-7","volume":"347","author":"AB Whitworth","year":"1996","unstructured":"Whitworth AB, Fischer F, Lesch OM, Limmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H, Fleischhacker WW (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. The Lancet 347:1438\u20131442","journal-title":"The Lancet"},{"key":"1515_CR44","first-page":"30","volume-title":"WHO global status report on alcohol","author":"World Health Organization","year":"2004","unstructured":"World Health Organization (2004) WHO global status report on alcohol. WHO, Geneva, pp 30\u201348"},{"issue":"1","key":"1515_CR45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(93)90682-8","volume":"231","author":"ML Zeise","year":"1993","unstructured":"Zeise ML, Kasparov S, Capogna M, Zieglg\u00e4nsberger W (1993) Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. Eur J Pharmacol 231(1):47\u201352","journal-title":"Eur J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1515-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-009-1515-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1515-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T17:09:47Z","timestamp":1739034587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-009-1515-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["1515"],"URL":"https:\/\/doi.org\/10.1007\/s00213-009-1515-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,25]]}}}